The severity of a patient’s chronic spontaneous urticaria impacted several outcomes, including quality of life and treatment ...

Acute urticaria (hives) is a common skin condition that affects up to 20% of people at some point in their lives. It can ...

Novartis' big-selling IgE inhibitor Xolair has been a mainstay of treatment for refractory chronic spontaneous urticaria (CSU ... also known as chronic hives. Xolair (omalizumab) has been around ...

The closely watched chronic spontaneous urticaria (CSU, or hives) space chalked more early stage KIT inhibitor data as Third Harmonic Bio Inc. rolled out results from the phase I single and multiple ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients ...

Novartis is just months away from filing for approval of oral BTK inhibitor remibrutinib as a treatment for chronic spontaneous urticaria – also known as chronic hives – after reporting long ...

Urticaria, or hives, can be either acute or chronic. In Chronic, there are two types, which are the company’s target indications. The target indications are - Chronic spontaneous urticaria (CSU ...